Jeffrey O'callaghan

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletes.

Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletes.

Journal: Science translational medicine
Published: March 18, 2026

Dynamic Inner Blood Retina Barrier Disruption in Retinitis Pigmentosa.

Dynamic Inner Blood Retina Barrier Disruption in Retinitis Pigmentosa.

Journal: Investigative ophthalmology & visual science
Published: January 14, 2026

Automated Assessment of Retinal Vascular Integrity Across Species.

Automated Assessment of Retinal Vascular Integrity Across Species.

Journal: Investigative ophthalmology & visual science
Published: December 15, 2025

EHD4 and ASAP2 are critical negative regulators of the claudin-5-based endothelial barrier.

EHD4 and ASAP2 are critical negative regulators of the claudin-5-based endothelial barrier.

Journal: The FEBS journal
Published: May 22, 2025

Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNS.

Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNS.

Journal: Cell reports
Published: April 25, 2025

p53 and the E3 Ubiquitin Ligase MDM2 in Glaucomatous Lamina Cribrosa Cells.

p53 and the E3 Ubiquitin Ligase MDM2 in Glaucomatous Lamina Cribrosa Cells.

Journal: International journal of molecular sciences
Published: September 24, 2024

Gene therapy for glaucoma: Targeting key mechanisms.

Gene therapy for glaucoma: Targeting key mechanisms.

Journal: Vision research
Published: July 31, 2024

Author Correction: Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.

Author Correction: Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.

Journal: Nature neuroscience
Published: April 16, 2024

Near-Complete Drusen Resolution With Brolucizumab: A Mechanism for Proinflammatory Mediated Drusen Clearance?

Near-Complete Drusen Resolution With Brolucizumab: A Mechanism for Proinflammatory Mediated Drusen Clearance?

Journal: Ophthalmic surgery, lasers & imaging retina
Published: June 23, 2023

Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.

Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.

Journal: Science advances
Published: April 19, 2023

Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.

Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.

Journal: Nature neuroscience
Published: November 16, 2022

Matrix Mechanotransduction via Yes-Associated Protein in Human Lamina Cribrosa Cells in Glaucoma.

Matrix Mechanotransduction via Yes-Associated Protein in Human Lamina Cribrosa Cells in Glaucoma.

Journal: Investigative ophthalmology & visual science
Published: January 11, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026